Regarding the differential effect of anti-hypertensive drugs on diabetic retinopathy, there is only weak clinical evidence that ACE-i (ACE inhibitors) and angiotensin II receptor (ARA-II) antagonists exert additional beneficial effects in slowing diabetic retinopathy progression independently of their hypotensive properties [14, 15]. This evidence concerns the gene ACE and diabetic retinopathy.